Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Expert Review of Vaccines
|
November 13, 2015
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Stephen S Whitehead
Cold Spring Harbor Perspectives in Biology
|
July 19, 2017
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination
Stephen S Whitehead, Kanta Subbarao
Current Topics in Microbiology and Immunology
|
October 6, 2009
Dengue vaccine candidates in development
Anna P Durbin, Stephen S Whitehead
Annual Review of Immunology
|
January 12, 2011
Immune response to dengue virus and prospects for a vaccine
Brian R Murphy, Stephen S Whitehead
The Journal of Infectious Diseases
|
December 22, 2017
Zika Vaccines: Role for Controlled Human Infection
Anna P Durbin, Stephen S Whitehead
Viruses
|
November 10, 2011
Next-generation dengue vaccines: novel strategies currently under development
Anna P Durbin, Stephen S Whitehead
Journal of Virology
|
April 10, 2015
Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice
Gregory D Gromowski, Cai-Yen Firestone, Stephen S Whitehead
Vaccine
|
October 27, 2015
WITHDRAWN: Dengue Human Infection Models to Advance Dengue Vaccine Development
Christian P Larsen, Stephen S Whitehead, Anna P Durbin
Vaccine
|
October 2, 2015
Dengue human infection models to advance dengue vaccine development
Christian P Larsen, Stephen S Whitehead, Anna P Durbin
Nature Reviews. Microbiology
|
June 15, 2007
Prospects for a dengue virus vaccine
Stephen S Whitehead, Joseph E Blaney, Anna P Durbin, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Expert Review of Vaccines
|
November 13, 2015
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Stephen S Whitehead
Cold Spring Harbor Perspectives in Biology
|
July 19, 2017
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination
Stephen S Whitehead, Kanta Subbarao
Current Topics in Microbiology and Immunology
|
October 6, 2009
Dengue vaccine candidates in development
Anna P Durbin, Stephen S Whitehead
Annual Review of Immunology
|
January 12, 2011
Immune response to dengue virus and prospects for a vaccine
Brian R Murphy, Stephen S Whitehead
The Journal of Infectious Diseases
|
December 22, 2017
Zika Vaccines: Role for Controlled Human Infection
Anna P Durbin, Stephen S Whitehead
Viruses
|
November 10, 2011
Next-generation dengue vaccines: novel strategies currently under development
Anna P Durbin, Stephen S Whitehead
Journal of Virology
|
April 10, 2015
Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice
Gregory D Gromowski, Cai-Yen Firestone, Stephen S Whitehead
Vaccine
|
October 27, 2015
WITHDRAWN: Dengue Human Infection Models to Advance Dengue Vaccine Development
Christian P Larsen, Stephen S Whitehead, Anna P Durbin
Vaccine
|
October 2, 2015
Dengue human infection models to advance dengue vaccine development
Christian P Larsen, Stephen S Whitehead, Anna P Durbin
Nature Reviews. Microbiology
|
June 15, 2007
Prospects for a dengue virus vaccine
Stephen S Whitehead, Joseph E Blaney, Anna P Durbin, et al.
Page
of 12